Ricardo D. Enriz

San Luis, D, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Structure-Based Design of New Series of Sulfonates with Potent and Specific BChE Inhibition and Anti-Inflammatory Effects.

Structure-Based Design of New Series of Sulfonates with Potent and Specific BChE Inhibition and Anti-Inflammatory Effects.

Journal: International journal of molecular sciences

Published: February 05, 2026

Integrated In Vitro and In Silico Profiling of Piperazinyl Thiosemicarbazone Derivatives Against Trypanosoma cruzi: Stage-Specific Activity and Enzyme Inhibition.

Integrated In Vitro and In Silico Profiling of Piperazinyl Thiosemicarbazone Derivatives Against Trypanosoma cruzi: Stage-Specific Activity and Enzyme Inhibition.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 23, 2025

A predictive acetylcholinesterase inhibition model: an integrated computational approach on alkaloids and synthetic derivatives.

A predictive acetylcholinesterase inhibition model: an integrated computational approach on alkaloids and synthetic derivatives.

Journal: Molecular diversity

Published: November 02, 2025

SD aromaticity index: a new assessment of aromaticity based on Ramsey spin dipolar contribution to NMR spin-spin coupling constants.

SD aromaticity index: a new assessment of aromaticity based on Ramsey spin dipolar contribution to NMR spin-spin coupling constants.

Journal: Physical chemistry chemical physics : PCCP

Published: October 22, 2025

N-Tosyl Hydrazone Benzopyran, a New Ligand of PPARα Obtained from Mapping the Conformational Space of Its Active Site.

N-Tosyl Hydrazone Benzopyran, a New Ligand of PPARα Obtained from Mapping the Conformational Space of Its Active Site.

Journal: Journal of chemical information and modeling

Published: December 25, 2024

Development of 2- and 3-prenylated quinolines and tetrahydroquinolines with PPAR activity: From hit to lead and a novel pan-PPAR agonist as a potential candidate for metabolic syndrome.

Development of 2- and 3-prenylated quinolines and tetrahydroquinolines with PPAR activity: From hit to lead and a novel pan-PPAR agonist as a potential candidate for metabolic syndrome.

Journal: Bioorganic chemistry

Published: December 23, 2024

New ATP-competitive inhibitors of E. coli GyrB obtained from the mapping of the hydrophobic floor at the binding site: synthesis and biological evaluation.

New ATP-competitive inhibitors of E. coli GyrB obtained from the mapping of the hydrophobic floor at the binding site: synthesis and biological evaluation.

Journal: RSC medicinal chemistry

Published: July 03, 2024

Exploring the interaction of N-(benzothiazol-2-yl)pyrrolamide DNA gyrase inhibitors with the GyrB ATP-binding site lipophilic floor: A medicinal chemistry and QTAIM study.

Exploring the interaction of N-(benzothiazol-2-yl)pyrrolamide DNA gyrase inhibitors with the GyrB ATP-binding site lipophilic floor: A medicinal chemistry and QTAIM study.

Journal: Bioorganic & medicinal chemistry

Published: May 08, 2024

Rosmarinic Acid Present in Lepechinia floribunda and Lepechinia meyenii as a Potent Inhibitor of the Adenylyl Cyclase gNC1 from Giardia lamblia.

Rosmarinic Acid Present in Lepechinia floribunda and Lepechinia meyenii as a Potent Inhibitor of the Adenylyl Cyclase gNC1 from Giardia lamblia.

Journal: Plants (Basel, Switzerland)

Published: January 29, 2024

Synthesis of a new 2-prenylated quinoline as potential drug for metabolic syndrome with pan-PPAR activity and anti-inflammatory effects.

Synthesis of a new 2-prenylated quinoline as potential drug for metabolic syndrome with pan-PPAR activity and anti-inflammatory effects.

Journal: Bioorganic & medicinal chemistry letters

Published: December 12, 2023

The Mechanism of Antimicrobial Small-Cationic Peptides from Coarse-Grained Simulations.

The Mechanism of Antimicrobial Small-Cationic Peptides from Coarse-Grained Simulations.

Journal: Journal of chemical information and modeling

Published: October 31, 2023

Second generation of pyrimidin-quinolone hybrids obtained from virtual screening acting as sphingosine kinase 1 inhibitors and potential anticancer agents.

Second generation of pyrimidin-quinolone hybrids obtained from virtual screening acting as sphingosine kinase 1 inhibitors and potential anticancer agents.

Journal: Bioorganic chemistry

Published: October 27, 2023

Showing 1-12 of 69

Last Updated: 09/26/2026